Oligonucleotide Therapeutics - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Representative image: Oracle (NYSE: ORCL) stock jumps 13% on record cloud earnings and multicloud momentum

Oracle (NYSE: ORCL) rallies 10% after earnings as $553bn RPO signals AI infrastructure dominance

Agentic AI arms race: Zendesk and Forethought challenge Salesforce Agentforce and ServiceNow Moveworks

Representative image of a cloud data center environment illustrating enterprise legacy system migration to Microsoft Azure, reflecting Kyndryl’s Cloud Uplift expansion in Canada to modernize mission-critical workloads while keeping data within national datacentre regions.

The quiet legacy cloud migration battle is heating up and Kyndryl just made a strategic move in Canada

Representative image of liquid-cooled AI server hardware inside a hyperscale data center, illustrating the type of direct-to-chip cooling infrastructure being developed through the Flex and Broadcom collaboration to support next-generation AI XPUs and high-density artificial intelligence workloads.

AI chips are overheating. Can Flex and Broadcom fix the cooling crisis?

GSK plc acquires Elsie Biotechnologies for $50 million, advancing its capabilities in oligonucleotide therapeutics and reinforcing its commitment to innovative healthcare solutions.

Read More

2 minute read

Pharma Industry News

GSK acquires Elsie Biotechnologies for up to $50m to enhance oligonucleotide therapeutics

GSK plc (LSE/NYSE: GSK), a global healthcare leader, has completed the acquisition of Elsie Biotechnologies, a private biotechnology…

byPallavi Madhiraju

June 8, 2024

web analytics